Faced with inevitable pain, most people choose to "get it out of the way" as soon as possible, according to research published this week in PLOS Computational Biology. In the study, which was conducted from the Institute for Global Health Innovation, Imperial College London, and the Wellcome Trust Centre for Neuroimaging, University College London, participants chose between real painful stimuli in the form of electric shocks, and imagined painful dental appointments occurring at different times in the future. Whilst most people chose to hasten the experience of pain, and would even accept more severe pain to avoid having to wait for it, a smaller proportion preferred to "put it off" into the future.
The anticipation of pain is a major source of misery. People who suffer from long-standing painful conditions report that the dread of worsening future pain can be more disabling than the pain itself. The general phenomenon is typically referred to as 'negative time preference'. The research team, led by Dr Giles Story, sought to better understand the fundamental processes by which people anticipate pain, with the hope of providing new insight into these conditions.
The researchers propose that the dread of pain increases as the predicted time of pain approaches. They demonstrate that if people focus only on the approaching pain itself, they will choose to defer pain into the future if possible, to reduce their immediate dread. By contrast, if people also take into account the dread they may experience in waiting for a painful event, the prospective unpleasantness of a prolonged period of dread may even exceed the unpleasantness of the pain itself. The researchers show that, in such cases, the prospect of pain becomes more unpleasant the more the pain is delayed, and people will therefore choose to expedite unavoidable pain.
The authors conclude that, "Further research is required to uncover the constitutive mechanisms of dread". For clinicians and health policy makers, a greater understanding of these mechanisms could inform the way in which potentially painful investigations and treatments are practised.
Financial disclosure: This work was supported by the Wellcome Trust [Ray Dolan Senior Investigator Award 098362/Z/12/Z]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Citation: Story GW, Vlaev I, Seymour B, Winston JS, Darzi A, et al. (2013) Dread and the Disvalue of Future Pain. PLoS Comput Biol 9(11): e1003335. doi:10.1371/journal.pcbi.1003335
Please add this link to the freely available article in online versions of your report (the link will go live when the embargo ends):
Name: Dr. Giles Story
Institution: Imperial College London, University College London
Department: Institute of Neurology, Wellcome Trust Centre for Neuroimaging
This press release refers to an upcoming article in PLOS Computational Biology. The release is provided by the article authors. Any opinions expressed in these releases or articles are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.
About PLOS Computational Biology
PLOS Computational Biology (http://www.ploscompbiol.org) features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. All works published in PLOS Computational Biology are open access. Everything is immediately available subject only to the condition that the original authorship and source are properly attributed. Copyright is retained.
About the Public Library of Science
The Public Library of Science (PLOS) is a nonprofit publisher and advocacy organization founded to accelerate progress in science and medicine by leading a transformation in research communication. PLOS engages in outreach activities that promote Open Access and innovations in the communication of research for scientists and the public. 2013 marks PLOS's tenth year as an Open Access publisher, reaching an international audience through immediate and free availability of research on the Internet. PLOS publishes a suite of seven journals: PLOS Biology, PLOS Medicine, PLOS Genetics, PLOS Computational Biology, PLOS Pathogens, and PLOS Neglected Tropical Diseases and PLOS ONE, which publishes research from more than 50 diverse scientific fields and is the largest journal in the world.
PLoS Computational Biology